LPL Financial
PLSE icon

LPL Financial’s Pulse Biosciences PLSE Stock Holding History

LPL Financial’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Buy
+9,851
New +$182K ﹤0.01% 5458
2025
Q4 		– Sell
-12,295
Closed -$218K – 6021
2025
Q3 		$218K Buy
+12,295
New +$195K ﹤0.01% 5291

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

LPL Financial's PLSE Position: Q1 2026 in Review

LPL Financial opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 9,851 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #5458 among its holdings. This is a return to the name: LPL Financial previously reported a position in PLSE as recently as Q3 2025.

LPL Financial first reported a position in PLSE in Q3 2025 and has held it in 2 quarters since. The position peaked at $218K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • LPL Financial held 9,851 shares of Pulse Biosciences worth $213K as of Q1 2026.
  • Pulse Biosciences was a new LPL Financial position in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5458 holding.
  • LPL Financial first reported a position in Pulse Biosciences in Q3 2025 and has held it in 2 quarters since.
  • LPL Financial's Pulse Biosciences position peaked at $218K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.